These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22326593)

  • 1. Cloning, expression and evaluation of the efficacy of a recombinant Entamoeba histolytica cysteine proteinase (EhCP4) antigen in minipig.
    He GZ; Feng Y; Deng SX; An CW
    Exp Parasitol; 2012 Apr; 130(4):412-5. PubMed ID: 22326593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the efficacy of a recombinant Entamoeba histolytica cysteine proteinase (EhCP112) antigen in minipig.
    He GZ; Deng SX; An CW
    Exp Parasitol; 2012 Jun; 131(2):258-60. PubMed ID: 22521909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entamoeba histolytica: cloning, expression and evaluation of the efficacy of a recombinant amebiasis cysteine proteinase gene (ACP1) antigen in minipig.
    He GZ
    Exp Parasitol; 2012 Feb; 130(2):126-9. PubMed ID: 22154977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the efficacy of a recombinant Entamoeba histolytica cysteine proteinase gene (EhCP5) antigen in Minipig.
    He GZ; Deng SX; Tian WY; Feng Y
    Exp Parasitol; 2012 Mar; 130(3):253-6. PubMed ID: 22202181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel Entamoeba histolytica cysteine proteinase, EhCP4, is key for invasive amebiasis and a therapeutic target.
    He C; Nora GP; Schneider EL; Kerr ID; Hansell E; Hirata K; Gonzalez D; Sajid M; Boyd SE; Hruz P; Cobo ER; Le C; Liu WT; Eckmann L; Dorrestein PC; Houpt ER; Brinen LS; Craik CS; Roush WR; McKerrow J; Reed SL
    J Biol Chem; 2010 Jun; 285(24):18516-27. PubMed ID: 20378535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The knockdown of each component of the cysteine proteinase-adhesin complex of Entamoeba histolytica (EhCPADH) affects the expression of the other complex element as well as the in vitro and in vivo virulence.
    Ocádiz-Ruiz R; Fonseca W; Linford AS; Yoshino TP; Orozco E; Rodríguez MA
    Parasitology; 2016 Jan; 143(1):50-9. PubMed ID: 26521708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with the Entamoeba histolytica surface metalloprotease EhMSP-1 protects hamsters from amebic liver abscess.
    Roncolato EC; Teixeira JE; Barbosa JE; Zambelli Ramalho LN; Huston CD
    Infect Immun; 2015 Feb; 83(2):713-20. PubMed ID: 25452550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant Entamoeba histolytica cysteine proteinase 1 to identify a potent inhibitor of amebic invasion in a human colonic model.
    Meléndez-López SG; Herdman S; Hirata K; Choi MH; Choe Y; Craik C; Caffrey CR; Hansell E; Chávez-Munguía B; Chen YT; Roush WR; McKerrow J; Eckmann L; Guo J; Stanley SL; Reed SL
    Eukaryot Cell; 2007 Jul; 6(7):1130-6. PubMed ID: 17513563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.).
    Abd Alla MD; Wolf R; White GL; Kosanke SD; Cary D; Verweij JJ; Zhang MJ; Ravdin JI
    Vaccine; 2012 Apr; 30(20):3068-75. PubMed ID: 22406457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pcDNA-Ehcpadh vaccine against Entamoeba histolytica elicits a protective Th1-like response in hamster liver.
    Martínez MB; Rodríguez MA; García-Rivera G; Sánchez T; Hernández-Pando R; Aguilar D; Orozco E
    Vaccine; 2009 Jun; 27(31):4176-86. PubMed ID: 19406180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards development of a vaccine for amebiasis.
    Stanley SL
    Clin Microbiol Rev; 1997 Oct; 10(4):637-49. PubMed ID: 9336666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entamoeba histolytica Interaction with Enteropathogenic Escherichia coli Increases Parasite Virulence and Inflammation in Amebiasis.
    Fernández-López LA; Gil-Becerril K; Galindo-Gómez S; Estrada-García T; Ximénez C; Leon-Coria A; Moreau F; Chadee K; Tsutsumi V
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31527129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retraction notice to "Cloning, expression and evaluation of the efficacy of a recombinant Entamoeba histolytica cysteine proteinase (EhCP4) antigen in Minipig" [YEXPR 130/4 (2012) 412-415].
    He GZ; Feng Y; Deng SX; An CW
    Exp Parasitol; 2018 Oct; 193():67. PubMed ID: 30266140
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant expression and purification of an enzymatically active cysteine proteinase of the protozoan parasite Entamoeba histolytica.
    Hellberg A; Nowak N; Leippe M; Tannich E; Bruchhaus I
    Protein Expr Purif; 2002 Feb; 24(1):131-7. PubMed ID: 11812234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host-pathogen interaction in amebiasis and progress in vaccine development.
    Huston CD; Petri WA
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):601-14. PubMed ID: 9832261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obtaining of three recombinant antigens of Entamoeba histolytica and evaluation of their immunogenic ability without adjuvant in a hamster model of immunoprotection.
    González-Vázquez MC; Carabarin-Lima A; Baylón-Pacheco L; Talamás-Rohana P; Rosales-Encina JL
    Acta Trop; 2012 May; 122(2):169-76. PubMed ID: 22266120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EhADH112 recombinant polypeptide inhibits cell destruction and liver abscess formation by Entamoeba histolytica trophozoites.
    Martínez-López C; Orozco E; Sánchez T; García-Pérez RM; Hernández-Hernández F; Rodríguez MA
    Cell Microbiol; 2004 Apr; 6(4):367-76. PubMed ID: 15009028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.
    Min X; Feng M; Guan Y; Man S; Fu Y; Cheng X; Tachibana H
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004419. PubMed ID: 26824828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation of human secretory IgA1 and IgA2 by Entamoeba histolytica surface-associated proteolytic activity.
    Garcia-Nieto RM; Rico-Mata R; Arias-Negrete S; Avila EE
    Parasitol Int; 2008 Dec; 57(4):417-23. PubMed ID: 18571975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Entamoeba histolytica antigen devoid of enzymatic activity, but endowed with immunogenic and protective properties.
    Portnoy L; Oliva A; Antonio-Ramírez J; Castellanos C; del Muro R; Ortíz-Ortíz L
    Arch Invest Med (Mex); 1990; 21 Suppl 1():27-34. PubMed ID: 2136496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.